DXCM - デックスコム (DexCom Inc.) デックスコム

 DXCMのチャート


 DXCMの企業情報

symbol DXCM
会社名 DexCom Inc (デックスコム)
分野(sector) Health Care   ヘルスケア
産業(industry) Medical/Dental Instruments  
業種 医療機器_医療用品_ディストリビュ―タ―   医療関連(Health Care)
概要 事業概要 デクスコム(DexCom Inc.)は医療機器のメーカーである。同社は糖尿病患者および医療提供者が使用する継続的グルコースモニタリング(CGM)システムの設計、開発、および商品化に注力する。同社の製品はDexCom G4 PLATINUMとDexCom G5 Mobileで構成される。同社は第5世代CGMシステムを商業化する。同社の欧州連合(EU)、オーストラリア、ニュージーランド、アジアおよび中南米諸国、米国の米国食品医薬品局(FDA)の承認を得る同社の市場であるDexCom G4 PLATINUMをコンソーシアム・ユーロピーン・マーキング(CEマーク)のもとにある。共有リモート監視システムを備えたDexCom G4 PLATINUMは、患者の受信機と患者のiPhone、iPod touch、またはiPad上のアプリケーションとの間のワイヤレス接続を使用して、指定された受信者(フォロワー)のモバイルデバイス上のアプリケーションにグルコース情報を送信する。   デックスコムは米国の医療デバイスメ―カ―。糖尿病患者および病院用に血糖値測定器の設計、開発、商品化に従事。製品には通院患者用の「SEVEN PLUS」、「DexCom G4」、「DexCom G4 PLATINUM」、および病院用の「GlucoCLear」などがある。  DexCom, Inc. is a medical device manufacturing company. The firm engages in the design, development and commercialization of glucose monitoring systems for ambulatory use by people with diabetes. Its products include Dexcom G4 PLATINUM System, DexCom G5 Mobil, DexCom Share and Mobile apps. The company was founded by John F. Burd on May 1, 1999 and is headquartered in San Diego, CA.
本社所在地 6340 Sequence Drive San Diego CA 92121 USA
代表者氏名 Kevin R. Sayer ケビン・R・セイヤー
代表者役職名 Chairman of the Board President Chief Executive Officer 取締役会長兼最高経営責任者(CEO)
電話番号 +1 858-200-0200
設立年月日 36281
市場名 NASDAQ National Market System
ipoyear 2005年
従業員数 2990人
url www.dexcom.com
nasdaq_url https://www.nasdaq.com/symbol/dxcm
adr_tso
EBITDA EBITDA(百万ドル) -2.90000
終値(lastsale) 123.395
時価総額(marketcap) 10902655673.535
時価総額 時価総額(百万ドル) 10823.58
売上高 売上高(百万ドル) 832.50000
企業価値(EV) 企業価値(EV)(百万ドル) 10559.78
当期純利益 当期純利益(百万ドル) 100.30000
決算概要 決算概要 BRIEF: For the six months ended 30 June 2018 DexCom Inc. revenues increased 36% to $426.9M. Net income totaled $6M vs. loss of $38.8M. Revenues reflect an increase in demand for the Company's products and services due to favorable market conditions. Net Income reflects Interest income increase from $700K to $3.7M (income) Research and development decrease of 1% to $92M (expense).

 DXCMのテクニカル分析


 DXCMのニュース

   Walking Aids Market Trends, Growth, Future Demand, Opportunity Assessment and Investment Feasibility Analysis till 2027| Medtronic, Philips, OMRON, BioTelemetry, Apple, Dexcom, Abbott, Masimo, GE, Healthcare, Bio-Beat, iRhythm  2020/10/09 09:27:10 OpenPR
A Fresh Study Report titled “Walking Aids Market” has been presented by DBMR. It evaluates the key market trends, advantages, and factors that are pushing the overall growth of the market. The market size, growth, share, latest business trends, government
   Global Outlook for the Continuous Glucose Monitoring Systems Market to 2027, Featuring Profiles of Key Players Abbott Laboratories, DexCom Inc. and Medtronic Plc  2020/10/07 15:30:00 PR Newswire
DUBLIN, Oct. 7, 2020 /PRNewswire/ -- The "Continuous Glucose Monitoring Systems - Global Market Trajectory & Analytics" report has been added to ResearchAndMarkets.com's offering. Amid the COVID-19 crisis, the global market for Continuous Glucose Monitoring Systems estimated at US$1.8…
   Lilly and Dexcom team up on new program to help improve diabetes management  2020/10/07 10:30:00 PR Newswire
INDIANAPOLIS and SAN DIEGO, Oct. 7, 2020 /PRNewswire/ -- Eli Lilly and Company (NYSE: LLY) and DexCom, Inc. (NASDAQ: DXCM) announced today a joint program for U.S. healthcare providers (HCPs) about Lilly's new rapid-acting mealtime insulin Lyumjev™ (insulin lispro-aabc injection, 100…
   Wearable Technology in Healthcare Market With Top Players like Abbott Laboratories, ActionSense Ltd, AerBetic, Cosinuss GmbH, Debiotech S.A., Dexcom, dorsaVi Ltd, Ectosense, Elitac B.V., Epicore Biosystems  2020/10/07 05:19:47 OpenPR
Wearables were implemented in a wide variety of fields; however, they have their biggest healthcare ability to resolve spiralling healthcare costs, ageing demographics, and chronic disease burden. An off-the-shelf report on Wearable Technology in Healthcare Market which has been compiled after
   Diabetes Care Devices Market Worth USD 4.3 Billion by 2025 - Leading Companies are Medtronic plc (Ireland), B. Braun (Germany), DexCom, Inc. (US), Abbott (US), Ascensia Diabetes Care Holdings AS (Switzerland), LifeScan (US), AgaMatrix Holdings LLC (US)  2020/10/05 09:17:53 OpenPR
According to the new market research report "Diabetes Care Devices Market by Type (SMBG, CGMS, Lancets, Insulin Pumps, Insulin Pens, Insulin Syringes, Mobile Apps), Patient Care Settings (Hospitals & Specialty Clinics, Self & Home Care), and Country (Brazil, Russia, India,
   Dexcom Appoints Karen Dahut to Board of Directors  2020/08/12 12:30:00 Business Wire
SAN DIEGO--(BUSINESS WIRE)--Dexcom Appoints Karen Dahut to Board of Directors
   Dexcom Announces Upcoming Conference Presentation  2020/08/10 20:05:00 Business Wire
SAN DIEGO--(BUSINESS WIRE)--Dexcom Announces Upcoming Conference Presentation
   Dexcom makes controlling blood sugar far simpler for diabetes patients — and everyone else too  2020/07/31 16:30:47 VentureBeat
Dexcom's continuous glucose monitors can deliver results in real time to your smartphone, helping diabetics monitor their blood sugar levels with ease.
   Top Analyst Upgrades and Downgrades: AMD, Amgen, DexCom, eBay, FireEye, Kraft Heinz, 3M, Pfizer, Seagate, Sonos, Starbucks, T-Mobile and More  2020/07/29 13:11:03 24/7 Wall street
   What pandemic? DexCom Q2 top line up 34%, earnings up 541% (NASDAQ:DXCM)  2020/07/28 20:31:11 Seeking Alpha
DexCom (NASDAQ:DXCM) Q2 results: Revenues: $451.8M (+34.3%), Sensor & other sales: $364.5M (+40.0%). Net income: $46.3M (+541.0%); non-GAAP net income: $77
   Dexcom Announces Upcoming Conference Presentation  2020/08/10 20:05:00 Business Wire
SAN DIEGO--(BUSINESS WIRE)--Dexcom Announces Upcoming Conference Presentation
   Dexcom makes controlling blood sugar far simpler for diabetes patients — and everyone else too  2020/07/31 16:30:47 VentureBeat
Dexcom's continuous glucose monitors can deliver results in real time to your smartphone, helping diabetics monitor their blood sugar levels with ease.
   Top Analyst Upgrades and Downgrades: AMD, Amgen, DexCom, eBay, FireEye, Kraft Heinz, 3M, Pfizer, Seagate, Sonos, Starbucks, T-Mobile and More  2020/07/29 13:11:03 24/7 Wall street
   What pandemic? DexCom Q2 top line up 34%, earnings up 541% (NASDAQ:DXCM)  2020/07/28 20:31:11 Seeking Alpha
DexCom (NASDAQ:DXCM) Q2 results: Revenues: $451.8M (+34.3%), Sensor & other sales: $364.5M (+40.0%). Net income: $46.3M (+541.0%); non-GAAP net income: $77
   DexCom, Inc. 2020 Q2 - Results - Earnings Call Presentation (NASDAQ:DXCM)  2020/07/28 20:20:34 Seeking Alpha
The following slide deck was published by DexCom, Inc. in conjunction with their 2020 Q2 earnings call..

 関連キーワード  (医療機器_医療用品_ディストリビュ―タ― 米国株 デックスコム DXCM DexCom Inc.)

医療で使われる機器のこと。レントゲン装置やからだの断面を画像化できるMRI(磁気共鳴画像)装置など高機能機器を含め数多くの種類がある。医療現場で使われるため、正確で精密である点などが求められる。医療機器への需要は着実に高まっており、電機メーカーなどからの進出も進んでいる。

 twitter  (公式ツイッターやCEOツイッターなど)